A pellet that feels wrong, or a dose that seems to fade early, leaves a reader asking whether the change is a known pellet effect, a gradual wearing down or a reason to speak with a doctor. This page sorts those using the Endocrine Society's patient library.
Effects at the pellet site
The Endocrine Society lists a pellet coming out through the skin as a side effect of pellet therapy. It also lists site infection and bleeding, and marks both as rare.
For wider context, the Endocrine Society published a statement on testosterone replacement therapy.
A dose that wears down
According to the Endocrine Society, the dose decreases over time. Hypogonadism symptoms may return toward the end of the dose period.
Who is told not to use testosterone therapy
The Endocrine Society states that men with known or suspected prostate or breast cancer should not receive testosterone therapy. It says anyone who has, or is at risk for, heart disease or stroke should talk to their doctor about the risks. It adds that you should not use testosterone therapy if you are planning fertility.
For older men, a narrative review of testosterone therapy in men aged 50 and above covers evidence-based benefits and safety considerations.
What can wait and what needs a conversation
The pellet items fall into two groups. A fading dose and returning symptoms are gradual changes. A pellet coming out, infection or bleeding are changes you can see at the site.
The cancer, fertility and heart or stroke points are different. They concern who should be treated, so they belong in a conversation with a doctor.
First step and when to seek care
Note what changed, where on the body and when. Then tell the clinician who placed the pellets. If you are weighing treatment and any of the Endocrine Society's cautions applies to you, raise it with a doctor first.
The Endocrine Society hypogonadism library page is the source for the side effects and cautions above.